Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Procept Biorobotics Corp (NQ: PRCT )

80.12 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 80.12
Bid (Size) 76.95 (1)
Ask (Size) 84.50 (1)
Prev. Close 80.12
Today's Range 80.12 - 80.12
52wk Range 24.83 - 85.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Navigating 6 Analyst Ratings For PROCEPT BioRobotics
Via Benzinga
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. " 
Via Benzinga

Performance

YTD
+93.34%
+93.34%
1 Month
+6.74%
+6.74%
3 Month
+29.50%
+29.50%
6 Month
+70.47%
+70.47%
1 Year
+153.22%
+153.22%

More News

Read More
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
From PROCEPT BioRobotics
Via GlobeNewswire
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
Via Benzinga
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For PROCEPT BioRobotics
Via Benzinga
A Closer Look at 4 Analyst Recommendations For PROCEPT BioRobotics
Via Benzinga
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
Via Benzinga
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
Via Benzinga
Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
From PROCEPT BioRobotics
Via GlobeNewswire
3 Robotics Stocks to Sell in August Before They Crash & Burn
Via InvestorPlace
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Via MarketBeat
Why Intuitive Surgical Stock is Dominating the Medical Sector
Via MarketBeat
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
From PROCEPT BioRobotics
Via GlobeNewswire
You’ve Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever.
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
From PROCEPT BioRobotics
Via GlobeNewswire
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
From PROCEPT BioRobotics
Via GlobeNewswire
From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
From PROCEPT BioRobotics
Via GlobeNewswire
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
From PROCEPT BioRobotics
Via GlobeNewswire
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
Via Investor's Business Daily
PRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.